Morgan Stanley analysts reiterated a Overweight rating on AbbVie Inc. (NYSE:ABBV) on February 05, 2026.
AbbVie Inc. operates in the Healthcare sector. The stock currently trades at $218.69 with a market capitalization of $395.7B. The stock has gained 24.6% over the past 52 weeks.